Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Hansoh Pharmaceutical Group Company Limited clinical trials
Part of Stellar Infinity Company Ltd., which holds 64.41% as of 2025-12-31. Source
The registry lists 186 studies whose lead sponsor is Hansoh Pharmaceutical Group Company Limited or one of 3 companies grouped under it. 116 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Hansoh Pharmaceutical Group Company Limited studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hansoh Pharmaceutical Group Company Limited.
- Jiangsu Hansoh Pharmaceutical Co., Ltd.135 studies →Subsidiary
Something wrong?
- Hansoh BioMedical R&D Company47 studies →Subsidiary
Something wrong?
- Shanghai Hansoh Biomedical Co., Ltd4 studies →Subsidiary
Something wrong?
Focus areas
Conditions Hansoh Pharmaceutical Group Company Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 186. Browse all 186 →
- A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic AlterationsRecruitingNCT07824882Phase 2
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLCNot yet recruitingNCT07892625Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPNot yet recruitingNCT07885293Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque PsoriasisRecruitingNCT07879885Phase 2
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506RecruitingNCT07844967Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function.Not yet recruitingNCT07836504Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of HS-20197 in Participants With Advanced Solid TumorsNot yet recruitingNCT07834359Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNot yet recruitingNCT07822542Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian CancerNot yet recruitingNCT07821606Phase 3
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical CystectomyRecruitingNCT07468851Phase 1/2
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)RecruitingNCT06461156Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- HS-20117-2 Injection in Patients With Advanced Solid TumorsRecruitingNCT07775703Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C LevelsNot yet recruitingNCT07777003Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504Not yet recruitingNCT07770217Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque PsoriasisNot yet recruitingNCT07765628Phase 2
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504Not yet recruitingNCT07764692Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Mass Balance Study of [14C]HS-10504Not yet recruitingNCT07764705Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study to Evaluate the Long-term Safety of HS-10380 in Patients With SchizophreniaNot yet recruitingNCT07759869Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCNot yet recruitingNCT07754123Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase I Study of Single and Multiple Doses of HS-20136-2 Injection in Healthy or Obese ParticipantsNot yet recruitingNCT07716241Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCRecruitingNCT07645222Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung CancerNot yet recruitingNCT07685041Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia DisorderNot yet recruitingNCT07677384Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase I Study of HS-20108 in Participants With Advanced Solid TumorsRecruitingNCT06936735Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruitingNCT07621601Phase 3
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study of HS-20136-2 in Healthy ParticipantsNot yet recruitingNCT07483437Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.Not yet recruitingNCT07615413Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese Participants and Chinese Participants With Mild HypertensionNot yet recruitingNCT07609875Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of HS-10506 in Chinese Patients With Insomnia DisorderNot yet recruitingNCT07587385Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of HS-10587 in Patients With Advanced Solid TumorsNot yet recruitingNCT07567859Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.RecruitingNCT07283367Phase 1/2
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney DiseaseNot yet recruitingNCT07555054Phase 2
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of HS-20110 in Participants With Advanced Solid TumorsRecruitingNCT06892379Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult ParticipantsNot yet recruitingNCT07535970Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal HemoglobinuriaRecruitingNCT07470762Phase 1/2
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Phase 1 Study of HS-20152 in Healthy ParticipantsNot yet recruitingNCT07503015Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Efficacy and Safety Study of HS-10542 for IgA NephropathyNot yet recruitingNCT07474636Phase 2
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic AlterationsNot yet recruitingNCT07464327Phase 3
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction AdenocarcinomaRecruitingNCT07462923Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Phase Ib Study of HS-10504 Combined Therapy in NSCLCNot yet recruitingNCT07414953Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of HS-20122 in Patients With Advanced Solid TumorsRecruitingNCT06927570Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid TumorsRecruitingNCT07186452Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian CancerRecruitingNCT06855069Phase 3
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate CancerRecruitingNCT07115446Phase 1
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise AloneNot yet recruitingNCT07156500Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Phase 3 Study of HS-20094 in Patients With T2DMNot yet recruitingNCT07156539Phase 3
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of Aumolertinib in European Participants With Non-Small Cell Lung CancerRecruitingNCT07130916Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118RecruitingNCT06846710Phase 1
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.
- A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung CancerRecruitingNCT06417008Phase 2/3
Sponsor listed in the registry: Hansoh BioMedical R&D Company
- Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell CarcinomaRecruitingNCT07097935Phase 1/2
Sponsor listed in the registry: Jiangsu Hansoh Pharmaceutical Co., Ltd.